ZIM Laboratories At CPHI: 2022

View

CPHI Corporate Presentation

Stall Posters

View
MEDIA GALLERY

ZIM LABORATORIES LIMITED Corporate Film 2022

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

MEDIA GALLERY

Silicon India covers
Zim Laboratories

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

View

Press Releases

View All
2022
View

ZIM Laboratories Limited has been granted marketing authorization for Sildenafil 50 mg ODS by AEMPS.

2020

Zim Laboratories Limited has been granted marketing rights for Rizatriptan by Infarmed, for its European subsidiaries.

View
2022

ZIM Laboratories Limited and Hypera Pharma Group enter into an exclusive licensing agreement of Vitamin D3 Orally Disintegrating Strips.

View
2020

ZIM Laboratories Limited and Neuraxpharm enter into an exclusive co-development agreement

View